Sort by
Refine Your Search
-
Category
-
Program
-
Employer
-
Field
-
Council of Finland (RCF) for AI research, called the Finnish Center for Artificial Intelligence (FCAI). This project is further related to the European Laboratory for Learning and Intelligent Systems (ELLIS
-
University invites applications for 3-5 Doctoral Researcher positions in Generative Artificial Intelligence and Software Engineering. The selected researchers will explore topics at the intersection
-
on interactive Artificial Intelligence (AI). The research will focus on user studies and interactive AI systems. This position will be funded based on an initial 2-year contract + 2 years extension. The key idea
-
the flagship grant from the Research Council of Finland (RCF) for AI research, called the Finnish Center for Artificial Intelligence (FCAI). This project is further related to the European Laboratory
-
, and Oslo, as well as from the Mohamed Bin Zayed University of Artificial Intelligence, George Mason University, and the National Research Council of Canada. The city of Helsinki is the capital city of
-
to collaborate with the vibrant Aalto research community, including the Intelligent Robotics group and the Mobile Robotics group , as well as the Finnish Center for Artificial Intelligence . The group also
-
, at the Division of Pharmaceutical Chemistry and Technology. Our aim is to create new machine learning and artificial intelligence methods to accelerate drug development. The successful candidate will contribute
-
from the Universities of Tübingen, Bucharest, and Oslo, as well as from the Mohamed Bin Zayed University of Artificial Intelligence, George Mason University, and the National Research Council of Canada
-
communities. The particular focus is to enhance the Joint Species Distribution Modelling to meet the challenges introduced by the analysis of ecological data collected with modern technologies and artificial
-
drug design” is led by Docent Juri Timonen, at the Division of Pharmaceutical Chemistry and Technology. Our aim is to create new machine learning and artificial intelligence methods to accelerate drug